Misplaced Pages

LY-344545: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 17:08, 19 April 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (← Previous edit Revision as of 13:59, 3 September 2011 edit undoBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBotNext edit →
Line 1: Line 1:
{{drugbox {{Drugbox
| verifiedrevid = 280823046 | verifiedrevid = 280823046
| IUPAC_name = | IUPAC_name =
| image = LY-344,545_structure.png | image = LY-344,545_structure.png
| width = 160 | width = 160

⚫ | CAS_number =
<!--Clinical data-->
⚫ | ATC_prefix =
| ATC_suffix = | tradename =
| PubChem = | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| DrugBank = | pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
⚫ | C=20|H=19|N=1|O=5
⚫ | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
⚫ | molecular_weight = 353.37 g/mol
⚫ | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| bioavailability =
⚫ | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
⚫ | protein_bound =
⚫ | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
⚫ | metabolism =
⚫ | legal_status =
⚫ | elimination_half-life =
⚫ | routes_of_administration =
⚫ | excretion =

| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
<!--Pharmacokinetic data-->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category= | bioavailability =
⚫ | protein_bound =
⚫ | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
⚫ | metabolism =
⚫ | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫ | elimination_half-life =
⚫ | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
⚫ | excretion =
⚫ | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->

⚫ | legal_status =
<!--Identifiers-->
⚫ | routes_of_administration =
⚫ | CAS_number =
⚫ | ATC_prefix =
| ATC_suffix =
| PubChem =
| DrugBank =

<!--Chemical data-->
⚫ | C=20 | H=19 | N=1 | O=5
⚫ | molecular_weight = 353.37 g/mol
}} }}


Revision as of 13:59, 3 September 2011

Pharmaceutical compound
LY-344545
Chemical and physical data
FormulaC20H19NO5
Molar mass353.37 g/mol g·mol
  (verify)

LY-344,545 is a research drug developed by the pharmaceutical company Eli Lilly, which acts as an antagonist for the metabotropic glutamate receptor subtype mGluR5. It is an epimer of another metabotropic glutamate receptor antagonist, the mGluR2/3-selective LY-341,495.


Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.


References

  1. Ornstein PL, Bleisch TJ, Arnold MB, Kennedy JH, Wright RA, Johnson BG, Tizzano JP, Helton DR, Kallman MJ, Schoepp DD, Hérin M. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability. Journal of Medicinal Chemistry. 1998 Jan 29;41(3):358-78. PMID 9464367
  2. Doherty AJ, Palmer MJ, Bortolotto ZA, Hargreaves A, Kingston AE, Ornstein PL, Schoepp DD, Lodge D, Collingridge GL. A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices. British Journal of Pharmacology. 2000 Sep;131(2):239-44. PMID 10991916


Glutamate receptor modulators
Ionotropic glutamate receptor modulators
AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
KARTooltip Kainate receptor
NMDARTooltip N-Methyl-D-aspartate receptor
Metabotropic glutamate receptor modulators
Group I
mGluR1Tooltip Metabotropic glutamate receptor 1
mGluR5Tooltip Metabotropic glutamate receptor 5
Group II
mGluR2Tooltip Metabotropic glutamate receptor 2
mGluR3Tooltip Metabotropic glutamate receptor 3
Group III
mGluR4Tooltip Metabotropic glutamate receptor 4
mGluR6Tooltip Metabotropic glutamate receptor 6
mGluR7Tooltip Metabotropic glutamate receptor 7
mGluR8Tooltip Metabotropic glutamate receptor 8
See also: Receptor/signaling modulators • Ionotropic glutamate receptor modulators • Glutamate metabolism/transport modulators
Categories: